Is AbbVie Inc. (ABBV) Undervalued?
Based on the current stock price of $229.98 and a P/E ratio of 175.56,AbbVie Inc. has a PEG ratio of 34.09.
The Short Answer:
Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of 34.09, ABBV appears to be potentially overvalued relative to its growth rate of 5.15%.
Based on a PEG ratio of 21.51 (adjusted for dividends).
Compare ABBV vs Competitors
Use the calculator below to see how ABBV stacks up against other stocks in the same industry.
How we analyzed ABBV
We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 175.56and dividing it by the annual growth rate of 5.15%.
PEG = 175.56 (P/E) ÷ 5.15 (Growth) = 34.09
Frequently Asked Questions about ABBV
What is the current PEG Ratio for AbbVie Inc. (ABBV)?+
The current PEG Ratio for AbbVie Inc. is 34.09. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.
Is ABBV stock undervalued right now?+
Based on the PEG ratio of 34.09, AbbVie Inc. appears to be potentially overvalued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.
What is the PEGY Ratio for ABBV?+
The PEGY ratio for AbbVie Inc. is 21.51. This metric accounts for dividend yield (3.01%), providing a more complete valuation picture.